超微经皮肾镜和输尿管软镜在治疗肾结石中的感染控制及疗效的对比研究
发布时间:2018-08-06 19:58
【摘要】:目的分析超微经皮肾镜和输尿管软镜在治疗肾结石中的感染控制及疗效。方法选取2015年5月-2016年5月医院诊治的肾结石患者140例为研究对象,入选者自主选择疗法,超微经皮肾镜碎石术(UPCNL)组70例患者,输尿管软镜碎石术(URSL)组70例患者,分别观察两组患者术后肾功能、临床指标及术后不良反应。结果 UPCNL组患者在体内清石效果中的显效率及无效率分别为64.29%及5.71%,均优于URSL组患者50.00%及21.43%,两组患者疗效对比,差异有统计学意义(P0.05);UPCNL组患者在结石直径≤20mm的临床指标中,手术时间、术中出血量与清石率均优于URSL组患者,两组对比差异有统计学意义(P0.01);而在结石直径20mm的临床指标中,手术时间、术中出血量均显著增加,尤其术中出血量对比仍有明显差异(P0.01);治疗后,UPCNL组患者血红蛋白水平为(106.2±9.8)g·~(l-1),下降幅度较小,明显高于URSL组患者的(98.4±9.5)g·~(l-1),两组对比差异有统计学意义(P0.05),而两组患者血肌酐水平术前术后对比,无明显差异,说明两种疗法对患者的肾功能几乎无影响。结论采用超微经皮肾镜术和输尿管软镜术在治疗肾结石患者中,对不同结石大小患者的疗效有所区别,但整体上超微经皮肾镜术,术后结石并发症率低,疗效突出。
[Abstract]:Objective to analyze the infection control and efficacy of ultramicro percutaneous nephroscopy and soft ureteroscopy in the treatment of renal calculi. Methods from May 2015 to May 2016, 140 patients with renal calculi treated in hospital were selected, 70 patients in (UPCNL) group were selected, 70 patients in (URSL) group were treated with soft ureteral lithotripsy, 70 patients in (UPCNL) group and 70 patients in (URSL) group after ureteral soft endoscopy lithotripsy. Renal function, clinical indexes and postoperative adverse reactions were observed in two groups. Results the effective rate and invalid rate of UPCNL group were 64.29% and 5.71%, respectively, which were better than those of URSL group (50.00% and 21.43%). The difference between the two groups was statistically significant (P0.05) in the clinical index of stone diameter 鈮,
本文编号:2168831
[Abstract]:Objective to analyze the infection control and efficacy of ultramicro percutaneous nephroscopy and soft ureteroscopy in the treatment of renal calculi. Methods from May 2015 to May 2016, 140 patients with renal calculi treated in hospital were selected, 70 patients in (UPCNL) group were selected, 70 patients in (URSL) group were treated with soft ureteral lithotripsy, 70 patients in (UPCNL) group and 70 patients in (URSL) group after ureteral soft endoscopy lithotripsy. Renal function, clinical indexes and postoperative adverse reactions were observed in two groups. Results the effective rate and invalid rate of UPCNL group were 64.29% and 5.71%, respectively, which were better than those of URSL group (50.00% and 21.43%). The difference between the two groups was statistically significant (P0.05) in the clinical index of stone diameter 鈮,
本文编号:2168831
本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2168831.html
最近更新
教材专著